Loading clinical trials...
Loading clinical trials...
Anti-CD7 Universal CAR-T Cells for CD7+ T/NK Cell Hematologic Malignancies: a Multi-center, Uncontrolled Trial
Conditions
Interventions
CD7 UCAR-T cells
Fludarabine
+2 more
Locations
1
China
Department of Hematology, Xinqiao Hospital
Chongqing, Chongqing Municipality, China
Start Date
March 1, 2021
Primary Completion Date
June 1, 2022
Completion Date
June 1, 2023
Last Updated
June 28, 2021
NCT07388563
NCT06561048
NCT05679895
NCT06698003
NCT04752826
NCT06909877
Lead Sponsor
Xinqiao Hospital of Chongqing
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions